Casa
asdas

A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).

Por um escritor misterioso

Descrição
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. - Abstract - Europe PMC
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study - The Lancet
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Monthly improvements in paid work productivity: ankylosing spondylitis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Mean (A) ASDAS and (B) BASDAI up to Week 48. Safety Set (N=89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Ankylosing spondylitis: etiology, pathogenesis, and treatments
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Full article: POSTER PRESENTATIONS
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Mean (A) ASDAS and (B) BASDAI up to Week 48. Safety Set (N=89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Physical activity in ankylosing spondylitis: evaluation and analysis of an eHealth tool
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
New evidence on the management of spondyloarthritis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019, Advances in Rheumatology
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Treat-to-target in axial spondyloarthritis — what about physical function and activity?
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Recommendations for the management and treatment of ankylosing spondylitis – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
de por adulto (o preço varia de acordo com o tamanho do grupo)